Skip to main content
. 2016 Feb 1;3(3):166–179. doi: 10.1002/acn3.293

Figure 5.

Figure 5

Clinical scores showed tendency for worsening during the observation period for both treated and placebo groups. (A) Clinical scores of expanded disability status scale (EDSS), Scripps neurological rating scale (NRS), and multiple sclerosis functional composite (MSFC) for patients in active treatment and placebo cohorts. (B) Average cumulative contrast‐enhancing lesion (CEL) counts on brain MRI for patients in active treatment and placebo cohorts.